The latest news updates from the 2024 Symposium
This year’s recipient of the Susan G. Komen® Brinker Award for Scientific Distinction in Basic Science, Carlos Caldas, MD, FMedSci, was honored for his groundbreaking work in breast cancer genomics.
A pioneer in the fields of cancer genetics and personalized medicine, Olufunmilayo Olopade, MD, FAACR, will receive the William L. McGuire Memorial Lecture Award on Wednesday, December 8, at SABCS 2021.
The hybrid nature of this year’s SABCS would not have been possible without the generosity of numerous industry supporters.
Industry exhibitors will showcase their latest breast cancer treatments, products, and technologies during six onsite presentations scheduled tomorrow.
The 2021 SABCS opens today, the first of four days of world-class programming highlighting the highest quality, state-of-the-art clinical, translational, and basic research in breast cancer.
The workshop was designed to look closely at the different steps involved in the clinical research journey and provide guidance and advice, said moderator Aditya Bardia, MD, MPH.
Susan G. Komen® has selected Carlos Caldas, MD, FMedSci, and Judy E. Garber, MD, MPH, as the 2021 recipients of the Brinker Awards for Scientific Distinction.
SABCS and its co-sponsor, the American Association of Cancer Research (AACR), award scholarships every year to researchers to help their work be seen. The researchers are typically early in their career.
An exciting new competition, also known as gamification, is now open on the SABCS online meeting platform. Win badges — and prizes — for logging on and interacting.
SABCS attendees can learn about the need for molecular disease testing in breast cancer and how Signatera’s ultra-sensitive ctDNA technology can help.